877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Heterocyclic compound, Drugs acting on the nervous system, Psychopharmacology

Categories

Antipsychotics (3)
Atypical antipsychotics (3)
Cyclic compounds (3)
Dopamine antagonists (3)
Heterocyclic compounds (3)
Psychoactive drugs (3)
Aromatic compounds (2)
Chloroarenes (2)
Heterocyclic compounds (4 or more rings) (2)
Antidepressants (1)
Heterocyclic compounds (bridged-ring) (1)
Mood stabilizers (1)
Pharmaceuticals (1)
Piperazines (1)
Psychoanaleptics (1)
Six-membered rings (1)

Suppliers

AK Scientific (1)
Oakwood Chemical (1)

Asenapine (65576-45-6)  
ORG 5222  ·  saphris  ·  asenapine maleate
Asenapine, sold under the trade names Saphris and Sycrest, is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.
Lurasidone (367514-88-3, 367514-87-2)  
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013. It can be used alone or in combination with mood stabilizers such as lithium or valproate (e.g., Depakote).
Related searches
Polycyclic organic compounds
Heterocyclic compound
Drugs acting on the nervous system
Psychopharmacology